6
Participants
Start Date
September 28, 2020
Primary Completion Date
April 30, 2022
Study Completion Date
June 30, 2022
MetaNeb® System
The intervention device use in this study is The MetaNeb® System (Hill-Rom; St. Paul, MN). It is an FDA 510k cleared device (k124032), powered by compressed gas, that delivers oscillation and lung expansion (OLE) therapy using both continuous high-frequency oscillation (CHFO) and continuous positive expiratory pressure (CPEP). The device also provides supplemental oxygen when used with compressed oxygen and can deliver aerosol therapy during CPEP and/or CHFO. The therapy is indicated for mobilization of secretions, lung expansion therapy and the treatment and prevention of pulmonary atelectasis. The device also provides supplemental oxygen when used with compressed oxygen.
RECRUITING
Emory University, Atlanta
RECRUITING
Northwestern University, Evanston
Lead Sponsor
Emory University
OTHER
Northwestern University
OTHER
Hill-Rom
INDUSTRY